Intermittent fasting for mental health during perimenopause
Official title: Impact of Intermittent Fasting on the Mental Health of Perimenopausal Women
Run by American University of Beirut Medical Center · NCT07481513 · Data updated 2026-11-12
This trial will see if a 16/8 intermittent fasting plan helps improve mental health for women aged 45–55 who are in perimenopause.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 55 Years |
| Sex | Women only |
| Enrollment | 140 (estimated) |
| Sponsor | American University of Beirut Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Beirut) |
| Status | Recruiting |
| Started | September 23, 2025 |
| Main results expected | June 2026 |
| Study ends | December 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07481513 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 45–55 in perimenopause by STRAW criteria and the Menopausal Rating Scale, who speak English, are not on hormone therapy, and do not have major uncontrolled medical or current formal psychiatric conditions.
✕Probably not a fit
Women currently using hormone replacement therapy, with uncontrolled diabetes or other severe medical conditions, with a current DSM-5 psychiatric diagnosis, who have had surgical menopause, or who cannot attend visits at the Beirut center are unlikely to be eligible or to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This six-month randomized controlled trial at the American University of Beirut Medical Center will randomly assign about 98 perimenopausal women aged 45–55 to either a 16/8 intermittent fasting schedule or to follow Lebanese food-based dietary guidelines. Mental health outcomes will be measured with validated questionnaires and other standardized tools, and group differences will be analyzed using independent t-tests. Key exclusions include current hormone replacement therapy, uncontrolled major medical conditions, current DSM-5 psychiatric diagnoses, dementia, surgical menopause, pregnancy, and non–English speakers. The study aims to determine whether intermittent fasting offers a practical non-pharmacologic approach to improve mood, sleep, and cognitive symptoms during the perimenopausal transition.
Why it matters
Potential benefit: If successful, intermittent fasting could provide a non-drug option to reduce mood symptoms, improve sleep, and sharpen thinking for women in perimenopause.
How similar studies have gone: Some small studies in general adult populations suggest intermittent fasting can improve mood and cognition, but its effects specifically in perimenopausal women are largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants eligible in this study will be women between the ages of 45 and 55 who are in the perimenopausal stage as defined by the STRAW criteria and confirmed using the Menopausal Rating Scale (MRS). Exclusion Criteria: * Currently using hormone replacement therapy * Diagnosed with severe medical conditions that could interfere with fasting, including uncontrolled diabetes, heart disease, hypertension, cancer or kidney disease * Have a current formal mental health diagnosis as defined by the DSM-5, regardless of whether they are receiving medication or therapy * Experiencing any form of dementia * Have undergone surgical menopause, have premature ovarian failure, are currently undergoing chemotherapy or radiotherapy, or are ovarian cancer survivors * Are currently pregnant. undergoing treatment for endometriosis, have significant thyroid disorders, or are on any form of hormone therapy * Do not speak English * Participants who score greater than 0 on question 9 of the PHQ-9 (including suicidal ideation) will be removed from the trial and provided with mental health referrals to NGOs for support.
Where it's running
-
American University of Beirut Medical Center
Beirut, Lebanon Recruiting
Study contacts
- Principal investigator: Nadia T Dandan, PsyD — American University of Beirut Medical Center
- Study coordinator: Nadia T Dandan, PsyD
- Email: nd55@aub.edu.lb
- Phone: +9613795428
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding immune clues to depression in perimenopause
This study tests whether immune and epigenetic changes during perimenopause help explain why some women develop depression.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation
A online program tests a self-guided mindfulness app for distressed parents going through divorce or separation, to see if it helps parent and child wellbeing.
-
Plant extract supplement for menopausal symptoms in women around menopause
A plant-extract dietary supplement is being tested to see if it helps hot flashes and related symptoms in women aged 42–60 who are nearing or just past menopause, compared with a placebo.
-
Integrated digital e-clinic for mental health and reproductive health for women and adolescent girls in Jordan
This project tests a digital e-clinic to provide mental health, psychosocial support, and reproductive health information to women and adolescent girls in Jordan, including Syrian refugees.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.